Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2209 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 92.76 USD | -0.64% | -6.59% | -20.97% | +15.12% | 1.37 B USD | ||
| 2211 |  AAPG Ascentage Pharma Group International - American Depository Shar | 14.55 USD | -4.09% | -4.59% | -15.55% | -41.80% | 1.36 B USD | ||
| 2218 |  ANAB AnaptysBio, Inc. - Common Stock | 46.21 USD | +1.23% | -5.64% | -16.87% | +31.28% | 1.34 B USD | ||
| 2244 |  GHRS GH Research PLC - Ordinary Shares | 20.45 USD | -2.90% | -11.28% | -26.36% | +44.42% | 1.27 B USD | ||
| 2253 |  ORIC Oric Pharmaceuticals, Inc. - Common Stock | 12.03 USD | +0.17% | -5.42% | -3.76% | -10.95% | 1.25 B USD | ||
| 2262 |  DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 14.00 USD | -1.75% | -4.96% | +1.45% | +262.69% | 1.23 B USD | ||
| 2265 |  REPL Replimune Group, Inc. - Common Stock | 13.04 USD | -1.21% | -4.75% | -9.88% | +179.83% | 1.23 B USD | ||
| 2277 |  TYRA Tyra Biosciences, Inc. - Common Stock | 19.97 USD | -2.06% | -6.02% | +5.44% | +39.26% | 1.19 B USD | ||
| 2302 |  BCAX Bicara Therapeutics Inc. - Common Stock | 17.26 USD | +5.12% | -5.37% | -26.14% | +19.53% | 1.14 B USD | ||
| 2310 |  VOR Vor Biopharma Inc. - Common Stock | 19.13 USD | +1.86% | +5.75% | -21.82% | +46.03% | 1.13 B USD | ||
| 2311 |  JANX Janux Therapeutics, Inc. - Common Stock | 18.50 USD | +3.24% | +7.25% | -3.50% | -29.31% | 1.13 B USD | ||
| 2321 |  LBRX LB Pharmaceuticals Inc - Common Stock | 34.61 USD | +1.32% | -8.24% | -29.47% | +130.58% | 1.12 B USD | ||
| 2330 |  NBTX Nanobiotix S.A. - ADSs | 22.90 USD | -6.99% | -16.39% | -38.09% | -14.07% | 1.11 B USD | ||
| 2332 |  MNKD MannKind Corporation - Common Stock | 3.42 USD | -0.87% | -14.71% | -17.79% | -35.47% | 1.10 B USD | ||
| 2384 |  MGTX MeiraGTx Holdings plc - Ordinary Shares | 10.50 USD | -2.96% | -2.33% | -21.64% | +20.00% | 1.01 B USD | ||
| 2398 |  CGEM Cullinan Therapeutics, Inc. - Common Stock | 15.46 USD | -1.09% | +4.74% | -26.35% | +117.75% | 994.92 M USD | ||
| 2401 |  SVRA Savara, Inc. - Common Stock | 4.83 USD | -1.02% | -5.29% | -9.55% | +40.82% | 992.37 M USD | ||
| 2404 |  IMTX Immatics N.V. - Ordinary Shares | 7.37 USD | -1.07% | -13.90% | -21.43% | -28.79% | 988.11 M USD | ||
| 2429 |  ANRO Alto Neuroscience, Inc. Common Stock | 24.02 USD | +2.08% | -7.97% | -28.30% | +295.07% | 942.60 M USD | ||
| 2434 |  KURA Kura Oncology, Inc. - Common Stock | 10.52 USD | -1.41% | -2.68% | -12.33% | +2.73% | 935.87 M USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |